Buys | $0 | 0 | 0 |
Sells | $3,879 | 1 | 100 |
Schiller Mark C. | Chief Legal Officer | 0 | $0 | 1 | $3,879 | $-3,879 |
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products …
Over the last 12 months, insiders at Kezar Life Sciences, Inc. have bought $0 and sold $3,879 worth of Kezar Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Kezar Life Sciences, Inc. have bought $4.42M and sold $1.31M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $295,400 was made by BERGER FRANKLIN M () on 2022‑03‑18.
2024-07-02 | Sale | Schiller Mark C. | Chief Legal Officer | 6,688 0.0084% | $0.58 | $3,879 | -86.86% | |
2023-02-06 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.88 | $275,320 | -69.99% | |
2023-02-03 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 25,000 0.0348% | $7.15 | $178,650 | -70.14% | |
2023-02-02 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 50,000 0.0681% | $7.19 | $359,500 | -70.86% | |
2023-02-01 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.95 | $278,000 | -68.99% | |
2023-01-31 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $7.08 | $212,400 | -70.01% | |
2023-01-30 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $6.91 | $207,300 | -68.71% | |
2023-01-25 | Sale | Morningside Venture Investments Ltd | director | 50,000 0.0697% | $6.85 | $342,500 | -67.35% | |
2023-01-24 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1103% | $6.98 | $558,400 | -68.05% | |
2023-01-23 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1109% | $6.81 | $544,800 | -66.76% | |
2023-01-17 | Sale | Morningside Venture Investments Ltd | director | 6,114 0.0088% | $6.79 | $41,514 | -64.18% | |
2023-01-13 | Sale | Morningside Venture Investments Ltd | director | 1,971 0.0029% | $7.15 | $14,093 | -65.50% | |
2023-01-12 | Sale | Morningside Venture Investments Ltd | director | 5,000 0.0068% | $6.77 | $33,850 | -65.80% | |
2023-01-06 | Sale | Morningside Venture Investments Ltd | director | 3,000 0.0042% | $6.89 | $20,670 | -65.20% | |
2023-01-05 | Sale | Morningside Venture Investments Ltd | director | 12,162 0.017% | $6.97 | $84,769 | -65.51% | |
2023-01-04 | Sale | Morningside Venture Investments Ltd | director | 30,000 0.0414% | $7.17 | $215,100 | -66.90% | |
2023-01-03 | Sale | Morningside Venture Investments Ltd | director | 500 0.0007% | $7.10 | $3,550 | -65.66% | |
2022-12-29 | Sale | Morningside Venture Investments Ltd | director | 25,000 0.0375% | $7.10 | $177,500 | -66.15% | |
2022-10-04 | Sale | Morningside Venture Investments Ltd | director | 3,612 0.0056% | $8.82 | $31,857 | -64.16% | |
2022-10-03 | Sale | Morningside Venture Investments Ltd | director | 28,700 0.0425% | $8.78 | $251,957 | -65.34% |
Equal Talent Investments Ltd | 10 percent owner | 6254545 85.6787% | $36.15M | 1 | 0 | +13.64% |
Morningside Venture Investments Ltd | 10 percent owner | 5447993 74.63% | $31.49M | 2 | 19 | +69.08% |
Cormorant Asset Management, LP | 10 percent owner | 1572909 21.5467% | $9.09M | 1 | 0 | |
BERGER FRANKLIN M | 890691 12.2012% | $5.15M | 4 | 0 | +10.22% | |
BAY CITY CAPITAL LLC | 10 percent owner | 622229 8.5237% | $3.6M | 1 | 0 |
$4,273,853 | 101 | -36.67% | $40.54M | |
$1,695,621 | 55 | 17.90% | $42.86M | |
$15,956,086 | 53 | 5.33% | $47.48M | |
$140,938,207 | 36 | 14.75% | $40.58M | |
$160,539,875 | 21 | -6.57% | $48.46M |
Increased Positions | 20 | +23.53% | 691,969 | +12.83% |
Decreased Positions | 38 | -44.71% | 2M | -34.89% |
New Positions | 6 | New | 264,240 | New |
Sold Out Positions | 23 | Sold Out | 306,908 | Sold Out |
Total Postitions | 67 | -21.18% | 4M | -22.06% |
Tang Capital Management Llc | $4,226.00 | 10.29% | 720,000 | +355,970 | +97.79% | 2024-12-31 |
Suvretta Capital Management, Llc | $4,207.00 | 10.24% | 716,759 | 0 | 0% | 2024-12-31 |
Avidity Partners Management Lp | $2,950.00 | 7.18% | 502,600 | 0 | 0% | 2024-12-31 |
Vanguard Group Inc | $1,609.00 | 3.92% | 274,111 | 0 | 0% | 2024-12-31 |
Orbimed Advisors Llc | $1,131.00 | 2.75% | 192,700 | 0 | 0% | 2024-12-31 |
Adar1 Capital Management, Llc | $865.00 | 2.11% | 147,404 | -1M | -88.99% | 2024-12-31 |
Acadian Asset Management Llc | $855.00 | 2.08% | 145,666 | -12,046 | -7.64% | 2024-12-31 |
Affinity Asset Advisors, Llc | $835.00 | 2.03% | 142,316 | -108,862 | -43.34% | 2024-12-31 |
Peapod Lane Capital Llc | $728.00 | 1.77% | 123,994 | +123,994 | New | 2024-12-31 |
Stonepine Capital Management, Llc | $646.00 | 1.57% | 110,000 | -39,131 | -26.24% | 2024-12-31 |